|
Observational Monocentric Study on Biliary Tract Cancer (BABEL)
RECRUITINGSponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Actively Recruiting
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Started2021-05-15
Est. completion2025-05-15
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05942807
Summary
BABEL is an observational, single-center, prospective study about patients affected by biliary tract cancers (BTC) treated at the Medical Oncology Unit of the FPUAG - IRCCS.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Patients with biliary tract cancer; * Patients with radiological evident disease; * Patients \>18 anni; * Written informed consent; * Patients with at least one oncological visit. Exclusion Criteria: * Patients without available clinical data; * Patients without histological diagnosis of BTC; * Patients without written informed consent.
Conditions2
Biliary Tract CancerCancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Started2021-05-15
Est. completion2025-05-15
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05942807